1. Home
  2. WVE vs OLPX Comparison

WVE vs OLPX Comparison

Compare WVE & OLPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • OLPX
  • Stock Information
  • Founded
  • WVE 2012
  • OLPX 2014
  • Country
  • WVE Singapore
  • OLPX United States
  • Employees
  • WVE N/A
  • OLPX N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • OLPX Package Goods/Cosmetics
  • Sector
  • WVE Health Care
  • OLPX Consumer Discretionary
  • Exchange
  • WVE Nasdaq
  • OLPX Nasdaq
  • Market Cap
  • WVE 915.6M
  • OLPX 1.0B
  • IPO Year
  • WVE 2015
  • OLPX 2021
  • Fundamental
  • Price
  • WVE $9.76
  • OLPX $1.41
  • Analyst Decision
  • WVE Strong Buy
  • OLPX Hold
  • Analyst Count
  • WVE 16
  • OLPX 4
  • Target Price
  • WVE $20.00
  • OLPX $1.75
  • AVG Volume (30 Days)
  • WVE 1.6M
  • OLPX 992.5K
  • Earning Date
  • WVE 07-30-2025
  • OLPX 08-07-2025
  • Dividend Yield
  • WVE N/A
  • OLPX N/A
  • EPS Growth
  • WVE N/A
  • OLPX N/A
  • EPS
  • WVE N/A
  • OLPX N/A
  • Revenue
  • WVE $93,946,000.00
  • OLPX $423,083,000.00
  • Revenue This Year
  • WVE N/A
  • OLPX $1.32
  • Revenue Next Year
  • WVE $4.55
  • OLPX $3.12
  • P/E Ratio
  • WVE N/A
  • OLPX N/A
  • Revenue Growth
  • WVE N/A
  • OLPX N/A
  • 52 Week Low
  • WVE $5.04
  • OLPX $1.01
  • 52 Week High
  • WVE $16.74
  • OLPX $2.77
  • Technical
  • Relative Strength Index (RSI)
  • WVE 72.03
  • OLPX 49.58
  • Support Level
  • WVE $8.40
  • OLPX $1.27
  • Resistance Level
  • WVE $9.03
  • OLPX $1.47
  • Average True Range (ATR)
  • WVE 0.55
  • OLPX 0.09
  • MACD
  • WVE 0.06
  • OLPX -0.00
  • Stochastic Oscillator
  • WVE 98.53
  • OLPX 57.14

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About OLPX Olaplex Holdings Inc.

Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.

Share on Social Networks: